Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
HTLV-1 induces an inflammatory CD4+CD8+ T cell population in HTLV-1–associated myelopathy
Allison K. Maher, Aris Aristodemou, Nicolas Giang, Yuetsu Tanaka, Charles R.M. Bangham, Graham P. Taylor, Margarita Dominguez-Villar
Allison K. Maher, Aris Aristodemou, Nicolas Giang, Yuetsu Tanaka, Charles R.M. Bangham, Graham P. Taylor, Margarita Dominguez-Villar
View: Text | PDF
Research Article Immunology

HTLV-1 induces an inflammatory CD4+CD8+ T cell population in HTLV-1–associated myelopathy

  • Text
  • PDF
Abstract

Human T cell leukemia virus type 1 (HTLV-1) is a retrovirus with preferential CD4+ T cell tropism that causes a range of conditions spanning from asymptomatic infection to adult T cell leukemia and HTLV-1–associated myelopathy (HAM), an inflammatory disease of the CNS. The mechanisms by which HTLV-1 induces HAM are poorly understood. By directly examining the ex vivo phenotype and function of T cells from asymptomatic carriers and patients with HAM, we show that patients with HAM have a higher frequency of CD4+CD8+ double-positive (DP) T cells, which are infected with HTLV-1 at higher rates than CD4+ T cells. Displaying both helper and cytotoxic phenotypes, these DP T cells are highly proinflammatory and contain high frequencies of HTLV-1–specific cells. Mechanistically, we demonstrate that DP T cells arise by direct HTLV-1 infection of CD4+ and CD8+ T cells. High levels of CD49d and CXCR3 expression suggest that DP T cells possess the ability to migrate to the CNS, and when cocultured with astrocytes, DP T cells induce proinflammatory astrocytes that express high levels of CXCL10, IFN-γ, and IL-6. These results demonstrate the potential of DP T cells to directly contribute to CNS pathology.

Authors

Allison K. Maher, Aris Aristodemou, Nicolas Giang, Yuetsu Tanaka, Charles R.M. Bangham, Graham P. Taylor, Margarita Dominguez-Villar

×

Figure 8

Origin of DP T cells in HTLV-1 infection.

Options: View larger image (or click on image) Download as PowerPoint
Origin of DP T cells in HTLV-1 infection.
(A) Representative plot showin...
(A) Representative plot showing CD4 and CD8 expression on sorted CD4+ SP and CD8+ SP T cells after coculture with JKT, MT2+R, or MT2 cells. (B and C) Line graphs showing the frequency of emerged DP T cells during coculture of SP T cells with JKT, MT2+R, or MT2 cells. (D and G) Representative dot plots showing CD4 and CD8 expression and Tax expression in SP T cells and DP T cells during coculture with MT2 cells (D) or MT2+R (G). (E and F) Line graphs showing Tax expression by SP T cells and the emerged DP T cells during coculture with MT2 cells. (H) Box-and-whisker plot showing Tax expression in CD4+ SP T cells, emerged DP T cells from CD4+ SP T cells, CD8+ SP T cells, emerged DP T cells from CD8+ SP T cells, and naturally occurring DP T cells on day 15 of coculture with MT2 cells (n = 4). Data are shown as mean ± SEM (n = 15) (B, C, E, and F). Wilcoxon signed-rank unpaired test was used. *P < 0.05, **P < 0.01 for comparisons between MT2 and MT2+R; #P < 0.05, ##P < 0.01 for comparisons between MT2 and JKT; $P < 0.05, $$P < 0.01, for comparisons between MT2+R and JKT (B and C). Wilcoxon signed-rank paired test was used. *P < 0.05, **P < 0.01, ***P < 0.001 for comparisons between SP T cells and DP T cells at each time point (E and F).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts